TRB-ILD1
/ Transpire Bio
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
October 15, 2025
TRB-ILD1 granted U.S. Orphan Drug Designation by the FDA for the treatment of Idiopathic Pulmonary Fibrosis (IPF)
(GlobeNewswire)
Orphan drug • Idiopathic Pulmonary Fibrosis
1 to 1
Of
1
Go to page
1